Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355

The European Society for Clinical Oncology (ESMO) Breast Cancer Conference was a hybrid event, held virtually and Berlin, Germany. This renowned meeting brought together global experts who disseminated the latest thinking in breast cancer. VJOncology had the opportunity to speak to Rupert Bartsch, Medical University Vienna, Vienna, Austria, Paolo Tarantino, Dana Farber Cancer Institute, Boston, MA, and Dave Cescon, Princess Margaret Cancer Centre, Toronto, Canada, who discussed the latest trial updates in breast cancer, including updates from the TUXEDO-1 (NCT04752059), monarchE (NCT03155997) and KEYNOTE-355 (NCT02819518) studies. The Breast Cancer Podcasts on VJOncology are supported by Seagen. Seagen have no influence over the production of the content